Skip to main content
. 2017 May 24;8(46):81285–81294. doi: 10.18632/oncotarget.18150

Figure 1. FK506 dose adjusted concentration related to CYP3A5 genotype.

Figure 1

FK506 blood concentrations A., FK506 standardized dose B., and dose normalized FK506 concentration C., of CYP3A5* GG recipients and CYP3A5* AA/AG recipients at 7th day, 1st month, 3rd month, 6th month and 12th month after the kidney transplantation. NS: not significant, **: p < 0.01, ****: p < 0.0001. Error bars in graphs indicates SEM.